About this Journal Submit a Manuscript Table of Contents
Case Reports in Urology
Volume 2013 (2013), Article ID 459618, 2 pages
http://dx.doi.org/10.1155/2013/459618
Case Report

Advanced Prostate Cancer Presenting as Hemolytic Uremic Syndrome

1Urology Department, Portuguese Institute of Oncology, 1099 Lisbon, Portugal
2Urology Department, Egas Moniz Hospital, CHLO, 1349 Lisbon, Portugal
3Nephrology Department, Santa Cruz Hospital, CHLO, 2790 Carnaxide, Portugal

Received 24 February 2013; Accepted 9 April 2013

Academic Editors: S.-S. Chen, A. Goel, G. L. Gravina, K. Madbouly, and F. Ramezanzadeh

Copyright © 2013 R. Ramos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Basic-Jukic, P. Kes, L. Bubic-Filipi, and B. Brunetta, “Treatment of thrombotic microangiopathies with plasma exchange,” Hematology, vol. 12, no. 1, pp. 63–67, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Biers, M. E. Sullivan, I. S. D. Roberts, and J. G. Noble, “Thrombotic microangiopathy in advanced prostatic carcinoma,” Urology, vol. 63, no. 2, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Mungall and P. Mathieson, “Hemolytic uremic syndrome in metastatic adenocarcinoma of the prostate,” American Journal of Kidney Diseases, vol. 40, no. 6, pp. 1334–1336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Perkovic, N. A. Came, A. P. Grigg, and G. J. Becker, “Haemolytic uraemic syndrome and prostatic cancer,” Australian and New Zealand Journal of Medicine, vol. 29, no. 3, pp. 383–384, 1999. View at Scopus
  5. N. J. Müller and B. C. Pestalozzi, “Hemolytic uremic syndrome in prostatic carcinoma,” Oncology, vol. 55, no. 2, pp. 174–176, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Innes, T. Bernard, R. E. Cotton, and R. P. Burden, “Recurrent haemolytic uraemic syndrome in the elderly associated with metastatic carcinoma,” Nephrology Dialysis Transplantation, vol. 5, no. 10, pp. 886–888, 1990. View at Scopus
  7. W. M. Van der Merwe and J. F. Collins, “The haemolytic uraemic syndrome and prostatic carcinoma,” The New Zealand Medical Journal, vol. 100, no. 829, pp. 483–485, 1987. View at Scopus
  8. M. Eugene, G. Deray, P. Cacoub, A. Achour, and A. Baumelou, “Hemolytic uremic syndrome and prostatic adenocarcinoma,” Clinical Nephrology, vol. 27, no. 1, p. 46, 1987. View at Scopus
  9. J. J. Sennesael, K. M. Vanden Houte, and H. D. Spapen, “Recurrent hemolytic uremic syndrome and metastatic malignancy,” American Journal of Nephrology, vol. 7, no. 1, pp. 60–64, 1987. View at Scopus
  10. J. Milutinovic, S. Irby, and M. Fisher, “Hemolytic uremic syndrome and metastatic malignancy,” Southern Medical Journal, vol. 75, no. 11, pp. 1409–1411, 1982. View at Scopus
  11. K. K. Francis, N. Kalyanam, D. R. Terrell, S. K. Vesely, and J. N. George, “Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 patients and a systematic review of published cases,” Oncologist, vol. 12, no. 1, pp. 11–19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. B. Lesesne, N. Rothschild, B. Erickson et al., “Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry,” Journal of Clinical Oncology, vol. 7, no. 6, pp. 781–789, 1989. View at Scopus